The effect of disease modifying therapies on fatigue in multiple sclerosis

被引：0
|
作者：
Rivera, Samantha Cruz [1 ]
Aiyegbusi, Olalekan Lee [1 ]
Meier, Daniela Piani [2 ]
Dunne, Achille [3 ]
Harlow, Danielle E. [4 ]
Henke, Christian [5 ]
Kamudoni, Paul [5 ]
Calvert, Melanie [1 ]
机构：
[1] Univ Birmingham, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England
[2] Ares Trading SA, Eysins, Switzerland
[3] Merck Healthcare KGaA, Darmstadt, Germany
[4] EMD Serono, Billerica, MA USA
[5] Merck KGaA, Darmstadt, Germany
来源：
QUALITY OF LIFE RESEARCH | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2072
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [31] Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
    Melamed, Esther
    Lee, Michael William
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [32] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
  • [33] Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
    Bross, Madeline
    Hackett, Melody
    Bernitsas, Evanthia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 15
  • [34] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [35] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [36] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Hartung, Daniel M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [37] Comparison of dropout rates of disease modifying therapies in multiple sclerosis
    Kurtuncu, M.
    Celik, S. Yildiz
    Coban, A.
    Shugaiv, E.
    Pehlivan, M.
    Akman-Demir, G.
    Eraksoy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 198 - 198
  • [38] Regulation of human glia by multiple sclerosis disease modifying therapies
    Healy, Luke M.
    Michell-Robinson, Mackenzie A.
    Antel, Jack P.
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (06) : 639 - 649
  • [39] Comparing the efficacy of disease-modifying therapies in multiple sclerosis
    Mitsikostas, Dimos D.
    Goodin, Douglas S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 109 - 116
  • [40] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
12345